PROCEPT BioRobotics Corporation Overview

Company Name: PROCEPT BioRobotics Corporation
Location: San Jose, California
Incorporation: Delaware
Primary Industry: Medical Devices/Robotics

Business Description

PROCEPT BioRobotics focuses on developing and commercializing innovative robotic systems for minimally invasive urological procedures. Their flagship technology likely involves robotic-assisted interventions in the treatment of prostate conditions, particularly benign prostatic hyperplasia (BPH). The company leverages advanced robotics and digital health solutions to improve patient outcomes and procedural efficiency.

Key Details

• Number of Employees: 54,818,700 shares of common stock outstanding as of February 20, 2025.
• Customer Base & Revenue: Specific number of customers, revenue, and income figures are not provided in this filing.
• Market Capitalization: As of June 30, 2024, the estimated market value of shares held by non-affiliates was approximately $3.1 billion.

Financial & Operational Highlights

• Revenue & Income: Not disclosed in the filing.
• Financial Performance: The document is a 10-K/A amendment, primarily adding an exhibit about the company's Insider Trading Compliance Policy, with no updates or changes to financial data included in this amendment.

Additional Notes

• The company is classified as a large accelerated filer.
• It has filed all required reports for the past 12 months.
• The registrant is not a shell company and has registered its common stock on NASDAQ under the trading symbol PRCT.

Summary

PROCEPT BioRobotics develops robotic-assisted medical technology targeting urological conditions, with a significant market presence valued at over $3 billion as of mid-2024. The detailed operational metrics such as revenue, number of customers, and profits are not specified in this document.